Catalyst Wire Dossier Catalyst Wire Dossier

Treprostinil (Tyvaso)

treprostinil · United Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Treprostinil (Tyvaso), covering 2025-10-30 to 2025-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia [Phase 2]

See pricing